secwatch.observer — SEC 8-K summary
======================================

Issuer:     Orchestra BioMed Holdings, Inc. (OBIO)
CIK:        0001814114
Form:       8-K
Filed at:   2023-06-08T23:59:59+00:00
Accession:  0001104659-23-069440
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Orchestra BioMed appoints Andrew Taylor as CFO, Bill Little as EVP Corp Dev
---------------------------------------------------------------------------

- Michael Kaswan stepped down as CFO effective June 6, 2023; will consult at $36,180/month for up to 6 months.
- Andrew Taylor appointed CFO; formerly CFO of Motus GI (MOTS), base salary $395,000, target bonus 50% of salary, initial equity grant of up to 278,502 RSUs or 417,544 options.
- Bill Little appointed EVP of Corporate Development and Strategy; previously COO of Neovasc until its acquisition by Shockwave Medical.
- Kaswan's consulting agreement includes $108,540 lump sum and additional three months' service vesting for equity.
- Little to focus on strategic collaborations; partnerships with Medtronic and Terumo continue.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1814114/000110465923069440/0001104659-23-069440-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1814114/000110465923069440/tm2318000d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-069440

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer